|
31 Jul 2008 |
Preliminary Cerepro Phase III Results Meet Primary Endpoint
|
|
30 Jul 2008 |
Quark Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in DME
|
|
30 Jul 2008 |
Medgenics Granted Approval to Commence Its Landmark Phase I/II Clinical Study of Epodure to Treat Anemia
|
|
26 Jul 2008 |
GlaxoSmithKline and the Harvard Stem Cell Institute announce a unique collaboration to enable the discovery of new medicines
|
|
23 Jul 2008 |
TOPIGEN Pharmaceuticals Completes Enrollment of Phase II Clinical Study of TPI ASM8 in Asthma
|
|
23 Jul 2008 |
ADVEXIN(R) Shows Statistically Significant Six-Month and Overall Survival Benefit as Compared to Methotrexate in Prospectively Defined Biomarker Patient Population
|
|
22 Jul 2008 |
Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
|
|
21 Jul 2008 |
Cenix BioScience GmbH Signs Research Agreement with Regulus Therapeutics (JOBS) for miRNA-Targeted Drug Discovery
|
|
16 Jul 2008 |
Dendreon Initiates Phase 2 Trial of PROVENGE in Patients with Localized Prostate Cancer Prior to Surgery
|
|
16 Jul 2008 |
Alnylam Announces Extension of RNAi Therapeutics Collaboration with Novartis
|
|
16 Jul 2008 |
MOLOGEN AG: First patient enrolled in clinical study with cancer therapy MGN1703
|
|
08 Jul 2008 |
BrainStorm Cell Therapeutics Inc. Study Positive for Spinal Cord Injuries
|
|
07 Jul 2008 |
Early findings show promise as AS1411 AML study proceeds to higher-dose stage
|
|
03 Jul 2008 |
VAVELTA(R) Phase II data presented at FACE
|
|
02 Jul 2008 |
MicroIslet Provides Safety and Efficacy Data Update
|
|
02 Jul 2008 |
Titan Pharmaceuticals Announces Spheramine(R) Initial Phase IIb Results
|
|
02 Jul 2008 |
Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles
|
|
30 Jun 2008 |
Introgen Submits ADVEXIN(R) Regulatory Applications in the U.S. and Europe
|
|
30 Jun 2008 |
Teva & ANP Announce That Atl/Tv1102, a Novel Drug for The Treatment Of Relapsing Remitting Multiple Sclerosis (Rrms), Demonstrated Significant Reduction In Disease Activity
|
|
25 Jun 2008 |
FDA approves Quark IND for DGFi, an siRNA therapeutic based on Silence Therapeutics’ Unique Proprietary Chemistry
|
|
25 Jun 2008 |
Osiris Therapeutics Announces $2 Million Milestone Payment for Clinical Progress of a Stem Cell Therapy for Type 1 Diabetes
|
|
22 Jun 2008 |
Oncolytics Biotech Inc. Announces U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
|
|
19 Jun 2008 |
Alnylam and Kyowa Hakko Form Alliance for the Development and Commercialization of ALN-RSV01 in Asia
|
|
18 Jun 2008 |
AVONTEC announces results of a multiple dose clinical phase I study with its drug candidate AVT-02 UE ointment after topical treatment in male healthy volunteers
|
|
17 Jun 2008 |
Aastrom to Initiate Phase II Clinical Trial Using Cardiac Repair Cells Derived From Patient's Own Bone Marrow for Treatment of Severe Chronic Heart Failure
|
